Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Zelcer, N

Class:Id	Person:194170
_displayName	Zelcer, N
_timestamp	2007-03-09 21:33:32
created	[InstanceEdit:194163] D'Eustachio, P, 2007-03-09 21:33:16
firstname	Noam
initial	N
surname	Zelcer
(author)	[LiteratureReference:194183] Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter [LiteratureReference:386999] ABC transporters in lipid transport [LiteratureReference:8854961] The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2 [LiteratureReference:8854975] Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor [LiteratureReference:8855264] LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor [LiteratureReference:9024426] Liver X receptors as integrators of metabolic and inflammatory signaling [LiteratureReference:9035144] EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux [LiteratureReference:9624291] The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation [LiteratureReference:9624292] Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists [LiteratureReference:9624311] Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein
[Change default viewing format]

No pathways have been reviewed or authored by Zelcer, N (194170)